Profil
Pamela A.
Swiggard worked as a Director of Regulatory Affairs at Endo Pharmaceuticals, Inc. and as a Vice President and Head of Regulatory Affairs at Trevena, Inc. She also worked as a VP of Regulatory Affairs and Quality Assurance at Fibrocell Science, Inc. Ms. Swiggard holds a graduate degree from Temple University and an undergraduate degree from The Pennsylvania State University.
Anciens postes connus de Pamela A. Swiggard
| Sociétés | Poste | Fin |
|---|---|---|
| FIBROCELL SCIENCE, INC. | Conseiller Juridique Général | 01/09/2018 |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Conseiller Juridique Général | - |
| TREVENA, INC. | Conseiller Juridique Général | - |
Formation de Pamela A. Swiggard
| The Pennsylvania State University | Undergraduate Degree |
| Temple University (Pennsylvania) | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TREVENA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
Fibrocell Science, Inc.
 Fibrocell Science, Inc. Pharmaceuticals: MajorHealth Technology Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on December 28, 1995 and is headquartered in Exton, PA. | Health Technology |